Back to Journals » ClinicoEconomics and Outcomes Research » Volume 3

The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease

Authors Ozkaya, Findik S, Gatici A

Published 17 January 2011 Volume 2011:3 Pages 15—18


Review by Single-blind

Peer reviewer comments 2

Sevket Ozkaya1, Serhat Findik2, Atilla Guven Atici2
1Rize University, Department of Pulmonary Medicine, Rize, Turkey; 2Ondokuz Mayis University, Department of Pulmonary Medicine, Atakum, Samsun, Turkey

Introduction: Chronic obstructive pulmonary disease (COPD) is a major public health problem. It imparts a substantial economic burden on individuals and society. Acute exacerbations are the main cause of hospital admissions and hospitalizations in patients with COPD in Turkey.
Objectives: We aimed to determine the costs of hospitalization in patients with acute exacerbations of COPD (AECOPD).
Results: A total of 7832 (1556 women, 6276 men) patients were hospitalized due to acute exacerbations of COPD between 2005–2009 in the Samsun Chest Diseases and Thoracic Surgery Hospital, northern Turkey. The mean age was 64.6 ± 19.8 years old and median length of hospital stay was 14.8 ± 9.5 days. The mean cost per admission was US$718 ± 364. Drug costs accounted for the largest portion (53.5%) of the mean cost, followed by bed cost (19.6%). One hundred seventy-four (2.2%) of the total hospitalized patients with AECOPD died in hospital.
Conclusion: AECOPD continues to have both significant economic burden and high mortality rate.

Keywords: COPD, acute exacerbation, hospitalization, costs

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Other articles by this author:

Factors affecting patients’ comfort during fiberoptic bronchoscopy and endobronchial ultrasound

Yıldırım F, Özkaya Ş, Yurdakul AS

Journal of Pain Research 2017, 10:775-781

Published Date: 29 March 2017

The objective evaluation of obstructive pulmonary diseases with spirometry

Ozkaya S, Dirican A, Tuna T

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2009-2015

Published Date: 25 August 2016

The rapid effects of budesonide plus formoterol in patients with obstructive airway diseases

Bayiz H, Ozkaya S, Dirican A, Ece F

Drug Design, Development and Therapy 2015, 9:5287-5290

Published Date: 21 September 2015

Thrombolytic treatment (alteplase; rt-PA) in acute massive pulmonary embolism and cardiopulmonary arrest

Dirican A, Ozkaya S, Atas AE, Ulu EK, Kitapci I, Ece F

Drug Design, Development and Therapy 2014, 8:759-763

Published Date: 12 June 2014

The relationship between early reversibility test and maximal inspiratory pressure in patients with airway obstruction

Ozkaya S, Dirican A, Kaya SO, Karanfil RC, Bayrak MG, Bostancı O, Ece F

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:453-456

Published Date: 5 May 2014

Long-term results of external valvuloplasty in adult patients with isolated great saphenous vein insufficiency

Sarac A, Jahollari A, Talay S, Ozkaya S, Ozal E

Clinical Interventions in Aging 2014, 9:575-579

Published Date: 5 April 2014

Diagnostic efficacy of computed tomography-guided transthoracic needle aspiration and biopsy in patients with pulmonary disease

Tuna T, Ozkaya S, Dirican A, Findik S, Atici AG, Erkan L

OncoTargets and Therapy 2013, 6:1553-1557

Published Date: 5 November 2013

The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis

Tasci C, Ozkaya S, Ozkara B, Tozkoparan E, Ozkan M, Karadurmus N, Serdar M, Balkan A, Bilgic H

OncoTargets and Therapy 2012, 5:385-390

Published Date: 22 November 2012

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010